Exclusive

Exclusive Rachel Cohrs

STAT Plus: Medicare tasks a senior adviser with staffing its new drug pricing division

Exclusive Mario Aguilar

STAT Plus: Alzheimer’s clinical trials have a recruitment problem. Telehealth platform Ro thinks it can help 

Exclusive Casey Ross

STAT Plus: Epic overhauls popular sepsis algorithm criticized for faulty alarms

Exclusive Rachel Cohrs

STAT Plus: Medicare lays out the bureaucracy it will need to negotiate drug prices

Exclusive Rachel Cohrs

STAT Plus: Democrats concede to clean user fee agreement to fund FDA

Exclusive Rachel Cohrs

STAT Plus: White House pitches drug pricing reforms as a way to extend cancer patients’ lives

Exclusive Casey Ross

STAT Plus: Shakeup with Optum’s health data licensing sparks an outcry among scientists

Exclusive Rachel Cohrs

STAT Plus: Lawmaker requests investigation into HCA over billing practices

Exclusive Rachel Cohrs

STAT Plus: FDA funding negotiations heat up ahead of September deadline

Exclusive Mario Aguilar

STAT Plus: Calm’s head of science departs amid a shakeup at meditation app maker

Exclusive Allison DeAngelis

STAT Plus: Ex-Google CEO’s VC firm brings in hype-busting researcher to expand its biotech investments

Exclusive Ed Silverman

STAT Plus: Novartis reports two children died from acute liver failure after treatment with Zolgensma gene therapy

Exclusive Megan Molteni

Researchers revive abandoned technique in effort to make artificial human eggs in a test tube

Exclusive Matthew Herper and Lev Facher

STAT Plus: White House to launch effort to develop next generation of Covid vaccines

Exclusive Lev Facher

STAT Plus: Biden picks renowned cancer surgeon Monica Bertagnolli as NCI chief

Exclusive Lev Facher

STAT Plus: In the search for an ARPA-H director, the White House is zeroing in on DARPA veterans

Exclusive Ed Silverman

STAT Plus: A ‘veritable playground’: CVS whistleblower details how patients were charged higher drug prices

Exclusive Rachel Cohrs

STAT Plus: Klobuchar, Porter call for FTC to investigate price hikes by Janssen, Bristol Myers Squibb

Exclusive Helen Branswell

Genetic data indicate at least two separate monkeypox outbreaks underway, suggesting wider spread

Exclusive Nicholas Florko

STAT Plus: Senate FDA legislation will include dietary supplement, cosmetic reforms

Exclusive Rachel Cohrs

White House documents detail a looming squeeze on Covid-19 boosters

Exclusive Nicholas Florko

Prisons didn’t prescribe much Paxlovid or other Covid-19 treatments, even when they got the drugs

Exclusive Rick Berke

STAT Plus: Gates Foundation CEO has ‘zero expectation’ that Melinda French Gates will step down as co-chair after divorce

Exclusive Rachel Cohrs

White House’s Jen Psaki offered a binder full of Covid spending details. Taking a peek was a process

Exclusive Ed Silverman

STAT Plus: Justice Department probes Bausch Health over marketing for dermatology drugs

Exclusive Nicholas Florko

STAT Plus: Warren, Grassley threaten to slap FDA with a 30-day deadline for OTC hearing aid rules

Exclusive Matthew Herper

STAT Plus: Douglas Melton, noted stem cell researcher, leaves Harvard for Vertex to create diabetes treatments

Exclusive Lev Facher

STAT Plus: NIH’s cancer chief, Ned Sharpless, to step down

Exclusive Lev Facher

STAT Plus: Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist